Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on April 28, 2022. The filing addresses corporate governance changes, specifically the departure of a director and the appointment of a new director to the Board.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Director Resignation: Samuel E. Navarro resigned from the Board of Directors on April 28, 2022. The resignation was not the result of any disagreement regarding the Company's operations, policies, or practices.
- Director Appointment: James Klein was appointed to the Board on May 2, 2022, to fill the vacancy left by Mr. Navarro. His term expires at the 2022 annual meeting of stockholders.
- Compensation Arrangement: Mr. Klein will receive compensation consistent with market practices and the Company's non-employee director policy. Additionally, he was granted 50,000 nonqualified stock options (10-year term), with 50% vesting immediately and 50% vesting on the first anniversary of his appointment.
Outlook, Risks, and Management Commentary
The filing highlights Mr. Klein's extensive background, including over 30 years in the semi-conductor industry. He recently retired from Qorvo (formerly TriQuint) as President of Infrastructure and Defense Products (2015-2021) and previously served as President of Qorvo Biotechnologies (2020-2021). His earlier career included roles at Texas Instruments and Raytheon focused on advanced semi-conductor technologies. No specific risks, contingencies, or unusual items were disclosed in this report.
Investor Verification Checklist
- Verify the effective date of James Klein's appointment and the specific vesting schedule of his 50,000 stock options.
- Confirm the composition of the Board of Directors following Mr. Navarro's resignation.
- Review the Company's non-employee director compensation policy to understand the cash compensation component for Mr. Klein.
- Check for any subsequent filings regarding the 2022 annual meeting of stockholders where Mr. Klein's term is set to expire.